2016
DOI: 10.1016/j.ijmm.2016.07.003
|View full text |Cite
|
Sign up to set email alerts
|

Molecular characterisation of Czech Clostridium difficile isolates collected in 2013–2015

Abstract: Clostridium difficile is a leading nosocomial pathogen and molecular typing is a crucial part of monitoring its occurrence and spread. Over a three-year period (2013)(2014)(2015), clinical Clostridium difficile isolates from 32 Czech hospitals were collected for molecular characterisation. Of 2,201 C. difficile isolates, 177 (8%) were non-toxigenic, 2,024 (92%) were toxigenic (tcdA and tcdB) and of these, 677 (33.5%) carried genes for binary toxin production (cdtA, cdtB). Capillary-electrophoresis (CE) ribotyp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(15 citation statements)
references
References 43 publications
(34 reference statements)
0
14
0
1
Order By: Relevance
“…In this study, all C . difficile isolates were susceptible to metronidazole and vancomycin, including the virulent ribotypes 027 and 001/0072 that in other studies have been associated with resistance to various antimicrobials [ 2 , 50 ]. Of note, 87.7% of the isolates were resistant to clindamycin and 7.7% to moxifloxacin, results that contrast with those from the Pan-European longitudinal surveillance of antibiotic study which reported resistance of 39.9% and 49.6% to moxifloxacin and clindamycin, respectively [ 50 ].…”
Section: Discussionmentioning
confidence: 96%
“…In this study, all C . difficile isolates were susceptible to metronidazole and vancomycin, including the virulent ribotypes 027 and 001/0072 that in other studies have been associated with resistance to various antimicrobials [ 2 , 50 ]. Of note, 87.7% of the isolates were resistant to clindamycin and 7.7% to moxifloxacin, results that contrast with those from the Pan-European longitudinal surveillance of antibiotic study which reported resistance of 39.9% and 49.6% to moxifloxacin and clindamycin, respectively [ 50 ].…”
Section: Discussionmentioning
confidence: 96%
“…The C. difficile ribotypes 046 and 126 belong to ribotypes identified in stool samples from CDI hospitalised patients in the Czech Republic and Europe as well [ 18 , 38 ]. The role of the C. difficile ribotype 033 in human CDI still remains unclear due to the absence of toxins A/B [ 8 , 16 ].…”
Section: Discussionmentioning
confidence: 99%
“…Na současné epidemiologické situaci CDI v ČR se podílí rozšíření dvou ribotypů Clostridium difficile, ribotypu 001 a 176 (14) izolátů Clostridium difficile, která byla pozorována v jednotlivých nemocničních zařízeních tak i mezi nimi, což potvrzuje vyšší potenciál těchto ribotypů k šíření v nemocničním prostředí (6). Ačkoliv výše zmíněné ribotypy (001 a 176) dominující epidemiologické situaci v ČR jsou fylogeneticky odlišné (14) , jejich společným epidemiologickým znakem je popsaná rezistence hned k několika antimikrobním přípravkům a s tím spojená kumulace mechanismů rezistence (15). S výskytem výše zmíněných Clostridium difficile ribotypů (001 a 176) v ČR bylo analýzou 490 CDI epizod z 28 českých nemocnic signifikantně asociováno předchozí podávání fluorochinolonů (7).…”
Section: Marcela Krůtováunclassified